- Home
- ORGO vs AHH Comparison
ORGO vs AHH Comparison
Compare ORGO & AHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- AHH
- Stock Information
- Founded
- ORGO 1985
- AHH 1979
- Country
- ORGO United States
- AHH United States
- Employees
- ORGO N/A
- AHH N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- AHH Real Estate
- Sector
- ORGO Health Care
- AHH Finance
- Exchange
- ORGO Nasdaq
- AHH Nasdaq
- Market Cap
- ORGO 620.3M
- AHH 600.4M
- IPO Year
- ORGO N/A
- AHH 2013
- Fundamental
- Price
- ORGO $4.07
- AHH $6.72
- Analyst Decision
- ORGO Buy
- AHH Buy
- Analyst Count
- ORGO 3
- AHH 4
- Target Price
- ORGO $7.33
- AHH $8.38
- AVG Volume (30 Days)
- ORGO 765.7K
- AHH 625.6K
- Earning Date
- ORGO 11-06-2025
- AHH 11-03-2025
- Dividend Yield
- ORGO N/A
- AHH 12.23%
- EPS Growth
- ORGO N/A
- AHH N/A
- EPS
- ORGO N/A
- AHH 0.13
- Revenue
- ORGO $429,531,000.00
- AHH $544,168,000.00
- Revenue This Year
- ORGO $2.51
- AHH N/A
- Revenue Next Year
- ORGO $25.45
- AHH $2.61
- P/E Ratio
- ORGO N/A
- AHH $51.79
- Revenue Growth
- ORGO N/A
- AHH N/A
- 52 Week Low
- ORGO $2.61
- AHH $6.10
- 52 Week High
- ORGO $6.71
- AHH $11.35
- Technical
- Relative Strength Index (RSI)
- ORGO 40.27
- AHH 38.58
- Support Level
- ORGO $3.84
- AHH $6.58
- Resistance Level
- ORGO $4.40
- AHH $7.16
- Average True Range (ATR)
- ORGO 0.22
- AHH 0.14
- MACD
- ORGO -0.03
- AHH -0.02
- Stochastic Oscillator
- ORGO 26.79
- AHH 23.28
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About AHH Armada Hoffler Properties Inc.
Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It lease its properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting, real estate financing and real estate services. It generates maximum revenue from the retail real estate segment.